Cite

HARVARD Citation

    Varandas, C. et al. (2022). Serum IL‐22 binding protein as a marker for atopic dermatitis activity and response to dupilumab treatment. Clinical & experimental allergy. 52 (6), pp. 820-823. [Online]. 
  
Back to record